Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system

Jason L DeHart1* email, Erik S Zimmerman1* email, Orly Ardon1 email, Carlos MR Monteiro-Filho2 email, Enrique R Argañaraz2 email and Vicente Planelles1 email

Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of Medicine, 15 North Medical Drive East #2100 – Room 2520, Salt Lake City, UT 84112, USA

Laboratório de Farmacologia Molecular (CP 04536), Faculdade de Saude, Universidade de Brasília, 70919-970 Brasília, DF, Brazil

author email corresponding author email* Contributed equally

Virology Journal 2007, 4:57doi:10.1186/1743-422X-4-57

Published: 8 June 2007

Additional files

Additional file 1:

Cell cycle profiles for experiments on the role of the ubiquitin proteasome system in Vpr-induced G2 arrest, corresponding to data shown in Figure 1.

Format: JPEG Size: 621KB Download file

Additional file 2:

Cell cycle profiles for experiments on the role of DCAF1 in Vpr-, etoposide- and aphidicolin-induced G2 arrest, corresponding to data shown in Figure 2B.

Format: JPEG Size: 152KB Download file

Additional file 3:

Cell cycle profiles for experiments showing the dominan-negative activity of Vpr(R80A), corresponding to data shown in Figure 4.

Format: JPEG Size: 333KB Download file


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.